This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Jörg Ogorka: Innovator in Pharmaceutical Compositions
Introduction
Jörg Ogorka is a notable inventor based in Steinen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release oral compositions.
Latest Patents
Jörg Ogorka holds a patent for "Controlled release oral compositions comprising rivastigmine." This pharmaceutical composition is capable of releasing a therapeutically effective dose of the active agent, rivastigmine, in a time-controlled manner. His innovative approach enhances the efficacy of treatment for patients requiring this medication.
Career Highlights
Ogorka is associated with Novartis AG, a leading global healthcare company. His work focuses on advancing pharmaceutical technologies that improve patient outcomes. With a strong commitment to research and development, he has established himself as a key player in the industry.
Collaborations
Some of his notable coworkers include Oskar Michael Kalb and Rajen Dhirubhai Shah. Their collaborative efforts contribute to the success of various projects within the pharmaceutical sector.
Conclusion
Jörg Ogorka's contributions to pharmaceutical innovations, particularly in controlled release formulations, highlight his expertise and dedication to improving healthcare solutions. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile